Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis
Pamela Trillo Aliaga, Francesca Spada, Giulia Peveri, Vincenzo Bagnardi, Caterina Fumagalli, Alice Laffi, Manila Rubino, Lorenzo Gervaso, E. Guerini Rocco, Federica Pisa, Giuseppe Curigliano, Nicola Fazio
Topics & Concepts
MedicineTemozolomideInternal medicineMeta-analysisOncologyHazard ratioCochrane LibraryConfidence intervalNeuroendocrine tumorsChemotherapyNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesGlioma Diagnosis and Treatment